Invitae Corporation (NVTA): Price and Financial Metrics
NVTA Price/Volume Stats
| Current price | $0.02 | 52-week high | $0.02 |
| Prev. close | $0.02 | 52-week low | $0.02 |
| Day low | $0.02 | Volume | 6,533,000 |
| Day high | $0.02 | Avg. volume | 0 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 5.21M |
NVTA Stock Price Chart Interactive Chart >
Invitae Corporation (NVTA) Company Bio
Invitae Corporation is a company that utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for physicians and their patients. The company was founded in 2012 and is based in San Francisco, California.
Latest NVTA News From Around the Web
Below are the latest news stories about INVITAE CORP that investors may wish to consider to help them evaluate NVTA as an investment opportunity.
Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain StockInvitae (NVTA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen. |
Invitae Layoffs 2023: What to Know About the Latest NVTA Job CutsInvitae layoffs are a hot topic on Friday after the genetics company announced a 15% reduction of its workforce to reduce costs. |
Why Are Chinese Stocks Up Today?Chinese stocks are up on Friday as investors react to recent economic data that includes signs of recovering in the reigon. |
Invitae Divests Ciitizen Health Data Platform and Implements Further Cost CutsInvitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and announced strategic cost cuts, which will include a workforce reduction and other operating expense reductions. |
What Makes Invitae (NVTA) a New Buy StockInvitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
NVTA Price Returns
| 1-mo | N/A |
| 3-mo | -95.34% |
| 6-mo | -96.42% |
| 1-year | -98.35% |
| 3-year | -99.94% |
| 5-year | -99.91% |
| YTD | -96.81% |
| 2023 | -66.30% |
| 2022 | -87.82% |
| 2021 | -63.48% |
| 2020 | 159.21% |
| 2019 | 45.84% |
Continue Researching NVTA
Want to do more research on Invitae Corp's stock and its price? Try the links below:Invitae Corp (NVTA) Stock Price | Nasdaq
Invitae Corp (NVTA) Stock Quote, History and News - Yahoo Finance
Invitae Corp (NVTA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...